Literature DB >> 17926886

Tris buffer (THAM). An appraisal of its physiologic effects and clinical usefulness.

H L Bleich1, W B Schwartz.   

Abstract

It has been the purpose of this discussion to review critically the physiologic considerations and clinical evidence regarding the use of Tris buffer in the treatment of acid-base disorders. It is concluded that there is little current evidence, theoretical, experimental, or clinical, to support the view that Tris has a significant therapeutic role. Some possible exceptions to this general conclusion are considered.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 17926886     DOI: 10.1056/NEJM196604072741407

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  8 in total

1.  [Development, cause and significance of the hypoxic metabolism in burns].

Authors:  W T Ulmer; J Rehn; B Rasche; F Müller
Journal:  Klin Wochenschr       Date:  1968-09-01

2.  Apnoea after THAM administration in the newborn.

Authors:  N R Roberton
Journal:  Arch Dis Child       Date:  1970-04       Impact factor: 3.791

3.  [Contribution on buffer selection in the treatment of acidosis in newborn infants, with special reference to the buffer effect on respiration].

Authors:  D Berg; M Mülling; C Marcks; E Saling
Journal:  Arch Gynakol       Date:  1968

4.  The use of buffers.

Authors:  H H Delooz
Journal:  Intensive Care Med       Date:  1980-11       Impact factor: 17.440

5.  Physical exercise after induced alkalosis (bicarbonate or tris-buffer).

Authors:  W Kindermann; J Keul; G Huber
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1977-10-31

6.  Respiratory adjustment to chronic metabolic alkalosis in man.

Authors:  R M Goldring; P J Cannon; H O Heinemann; A P Fishman
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

Review 7.  Guidelines for the treatment of acidaemia with THAM.

Authors:  G G Nahas; K M Sutin; C Fermon; S Streat; L Wiklund; S Wahlander; P Yellin; H Brasch; M Kanchuger; L Capan; J Manne; H Helwig; M Gaab; E Pfenninger; T Wetterberg; M Holmdahl; H Turndorf
Journal:  Drugs       Date:  1998-02       Impact factor: 9.546

8.  Lactic acidosis with phenformin therapy.

Authors:  T Cleaver; R Carretta
Journal:  Calif Med       Date:  1972-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.